--2024/Q3-- / 0.000--
--2024/Q2-- / 0.000--
--2024/Q10.000 / 0.000--
--2023/Q40.000 / 0.000--
--2023/Q30.000 / 0.000--
--2023/Q2381.444M / 0.000--
--2023/Q10.000 / 0.000--
--2022/Q40.000 / 0.000--
--2022/Q30.000 / 0.000--
--2022/Q20.000 / 0.000--
US Stock MarketDetailed Quotes
ASLN Aslan Pharmaceuticals
- 0.3121
- -0.0480-13.33%
Close Jun 18 16:00 ET
- 0.3699
- +0.0578+18.52%
Post 19:14 ET
7.06MMarket Cap-156P/E (TTM)
0.3700High0.3100Low428.15KVolume0.3700Open0.3601Pre Close142.73KTurnover2.15%Turnover RatioLossP/E (Static)22.63MShares3.900052wk High-0.39P/B6.21MFloat Cap0.310052wk Low--Dividend TTM19.89MShs Float52.1950Historical High--Div YieldTTM16.66%Amplitude0.3100Historical Low0.3330Avg Price1Lot Size
Aslan Pharmaceuticals Key Stats
Aslan Pharmaceuticals Earnings Date
Currency: USD
Period
Q1 FY2024 Earnings
--
Revenue(YoY)
0.00
0.00%EPS(YoY)
-0.50
+60.00%Analyst Rating
May 31, 2024
Aslan Pharmaceuticals Earnings Estimates
Revenue
EPS
EBIT
Revenue is based on 2 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement
Currency: TWD
Actual
Estimate
Unlock Free Earnings Estimates
Open Account
Aslan Pharmaceuticals Earnings Reports
Read more
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg